Company
United StatesPublic company, NASDAQ: LINLinde Inc. (NASDAQ: LIN), Marietta, OH – FDA Inspections
Inspection records and compliance data for Linde Inc. in Marietta, Ohio. 3 FDA inspections on record, last inspected July 14, 2026. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc. based in Marietta, Ohio, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected December 22, 2011. Last inspected July 14, 2026.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 14, 2026 | Not classified | Human Drugs | 1330376 |
| September 25, 2015 | NAI | Human Drugs · Drug Quality Assurance | 944075 |
| December 22, 2011 | VAI | Human Drugs · Drug Quality Assurance | 765806 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
1514501
Address
2034 Blue Knob Rd, Marietta, Ohio 45750, United States
Country
United States
ID: b801d749-6136-4f60-bfc4-132d9b91db5a